Status:
UNKNOWN
COVID-19 and Social Isolation and Loneliness Trial
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborating Sponsors:
Bolton Clarke Research Institute
Sunnybrook Research Institute
Conditions:
Social Isolation
Loneliness
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
Social isolation and loneliness worsen older peoples' quality of life, risk of dementia, and contributes to 45,000 deaths/year in Canada - as much as smoking. Isolated people use the health care syste...
Eligibility Criteria
Inclusion
- Any community-dwelling person 70 years of age and older receiving care from the ED, Family Medicine, or Geriatric clinics at our two participating sites (MSH and NYGH) will be eligible.
Exclusion
- age less than 70 years; communication problems (critically ill, unconscious, language barrier, speech impairment or otherwise unable to provide consent), or admission to a hospital for \> 72 hours. Patients with severe cognitive impairment or those living in nursing homes who are dependent on others for their activity of daily living will be excluded. To target the intervention for older people with loneliness a baseline de Jonge loneliness scores of 2.0 will be required for participation in the trial.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 3 2023
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT05228782
Start Date
November 1 2021
End Date
November 3 2023
Last Update
February 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1XS